Annual Cash & Cash Equivalents
$4.93 M
-$7.14 M-59.16%
December 31, 2023
Summary
- As of February 26, 2025, CKPT annual cash & cash equivalents is $4.93 million, with the most recent change of -$7.14 million (-59.16%) on December 31, 2023.
- During the last 3 years, CKPT annual cash & cash equivalents has fallen by -$35.84 million (-87.91%).
- CKPT annual cash & cash equivalents is now -91.00% below its all-time high of $54.73 million, reached on December 31, 2021.
Performance
CKPT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.70 M
-$248.00 K-5.01%
September 30, 2024
Summary
- As of February 26, 2025, CKPT quarterly cash and cash equivalents is $4.70 million, with the most recent change of -$248.00 thousand (-5.01%) on September 30, 2024.
- Over the past year, CKPT quarterly cash and cash equivalents has increased by +$2.93 million (+165.41%).
- CKPT quarterly cash and cash equivalents is now -92.78% below its all-time high of $65.12 million, reached on June 30, 2021.
Performance
CKPT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CKPT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.2% | +165.4% |
| 3 y3 years | -87.9% | -77.0% |
| 5 y5 years | -77.6% | -78.1% |
CKPT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.0% | at low | -91.4% | +165.4% |
| 5 y | 5-year | -91.0% | at low | -92.8% | +165.4% |
| alltime | all time | -91.0% | at low | -92.8% | +165.4% |
Checkpoint Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.70 M(-5.0%) |
| Jun 2024 | - | $4.95 M(-56.0%) |
| Mar 2024 | - | $11.24 M(+128.1%) |
| Dec 2023 | $4.93 M(-59.2%) | $4.93 M(+178.1%) |
| Sep 2023 | - | $1.77 M(-76.1%) |
| Jun 2023 | - | $7.42 M(+53.1%) |
| Mar 2023 | - | $4.85 M(-59.8%) |
| Dec 2022 | $12.07 M(-78.0%) | $12.07 M(-41.1%) |
| Sep 2022 | - | $20.48 M(-33.7%) |
| Jun 2022 | - | $30.89 M(-25.5%) |
| Mar 2022 | - | $41.48 M(-24.2%) |
| Dec 2021 | $54.73 M(+34.2%) | $54.73 M(-9.1%) |
| Sep 2021 | - | $60.20 M(-7.6%) |
| Jun 2021 | - | $65.12 M(+8.5%) |
| Mar 2021 | - | $60.03 M(+47.2%) |
| Dec 2020 | $40.77 M | $40.77 M(-3.0%) |
| Sep 2020 | - | $42.03 M(+91.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $21.92 M(+2.1%) |
| Mar 2020 | - | $21.48 M(-17.6%) |
| Dec 2019 | $26.08 M(+18.6%) | $26.08 M(+99.7%) |
| Sep 2019 | - | $13.06 M(-1.1%) |
| Jun 2019 | - | $13.21 M(-6.7%) |
| Mar 2019 | - | $14.15 M(-35.7%) |
| Dec 2018 | $22.00 M(+14.4%) | $22.00 M(-25.7%) |
| Sep 2018 | - | $29.60 M(+4.6%) |
| Jun 2018 | - | $28.30 M(-18.8%) |
| Mar 2018 | - | $34.86 M(+81.3%) |
| Dec 2017 | $19.23 M(-45.2%) | $19.23 M(-17.9%) |
| Sep 2017 | - | $23.42 M(-14.0%) |
| Jun 2017 | - | $27.23 M(-15.7%) |
| Mar 2017 | - | $32.30 M(-7.9%) |
| Dec 2016 | $35.09 M(-30.4%) | $35.09 M(-10.8%) |
| Sep 2016 | - | $39.35 M(-21.9%) |
| Dec 2015 | $50.42 M | $50.42 M |
FAQ
- What is Checkpoint Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics annual cash & cash equivalents year-on-year change?
- What is Checkpoint Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Checkpoint Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CKPT is $4.93 M
What is the all time high annual cash & cash equivalents for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high annual cash & cash equivalents is $54.73 M
What is Checkpoint Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CKPT annual cash & cash equivalents has changed by -$7.14 M (-59.16%)
What is Checkpoint Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CKPT is $4.70 M
What is the all time high quarterly cash and cash equivalents for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high quarterly cash and cash equivalents is $65.12 M
What is Checkpoint Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CKPT quarterly cash and cash equivalents has changed by +$2.93 M (+165.41%)